The tenofovir pre-exposure prophylaxis trial in Thailand: researchers should show more openness in their engagement with the community.
Chua
Arlene
A
Ford
Nathan
N
Wilson
David
D
Cawthorne
Paul
P
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D019058:Community Networks; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006806:Human Rights; D006801:Humans; D018671:Needle-Exchange Programs; D063065:Organophosphonates / Q000627:therapeutic use*; D010344:Patient Advocacy; D012107:Research Design; D019966:Substance-Related Disorders / Q000150:complications; D000068698:Tenofovir; D013785:Thailand
D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine